- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
According to our latest study, the global Therapeutic Nuclear Medicines market size was valued at USD 1719.4 million in 2022 and is forecast to a readjusted size of USD 5230.4 million by 2029 with a CAGR of 17.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
This report is a detailed and comprehensive analysis for global Therapeutic Nuclear Medicines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Therapeutic Nuclear Medicines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Therapeutic Nuclear Medicines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Therapeutic Nuclear Medicines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Therapeutic Nuclear Medicines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Therapeutic Nuclear Medicines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Therapeutic Nuclear Medicines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed and Curium Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Therapeutic Nuclear Medicines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Market segment by Application
Thyroid
Bone Metastasis
Lymphoma
Other
Major players covered
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines from 2018 to 2023.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Therapeutic Nuclear Medicines.
Chapter 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Therapeutic Nuclear Medicines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Radium-223
1.3.3 Lutetium-177
1.3.4 Iodine-131
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Therapeutic Nuclear Medicines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Thyroid
1.4.3 Bone Metastasis
1.4.4 Lymphoma
1.4.5 Other
1.5 Global Therapeutic Nuclear Medicines Market Size & Forecast
1.5.1 Global Therapeutic Nuclear Medicines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Therapeutic Nuclear Medicines Sales Quantity (2018-2029)
1.5.3 Global Therapeutic Nuclear Medicines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Therapeutic Nuclear Medicines Product and Services
2.1.4 Novartis AG Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis AG Recent Developments/Updates
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Therapeutic Nuclear Medicines Product and Services
2.2.4 Bayer Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bayer Recent Developments/Updates
2.3 China Isotope & Radiation
2.3.1 China Isotope & Radiation Details
2.3.2 China Isotope & Radiation Major Business
2.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
2.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 China Isotope & Radiation Recent Developments/Updates
2.4 Q BioMed
2.4.1 Q BioMed Details
2.4.2 Q BioMed Major Business
2.4.3 Q BioMed Therapeutic Nuclear Medicines Product and Services
2.4.4 Q BioMed Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Q BioMed Recent Developments/Updates
2.5 Curium Pharmaceuticals
2.5.1 Curium Pharmaceuticals Details
2.5.2 Curium Pharmaceuticals Major Business
2.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
2.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Curium Pharmaceuticals Recent Developments/Updates
2.6 Jubilant DraxImage
2.6.1 Jubilant DraxImage Details
2.6.2 Jubilant DraxImage Major Business
2.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
2.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jubilant DraxImage Recent Developments/Updates
2.7 Dongcheng
2.7.1 Dongcheng Details
2.7.2 Dongcheng Major Business
2.7.3 Dongcheng Therapeutic Nuclear Medicines Product and Services
2.7.4 Dongcheng Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Dongcheng Recent Developments/Updates
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business
2.8.3 Lantheus Therapeutic Nuclear Medicines Product and Services
2.8.4 Lantheus Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lantheus Recent Developments/Updates
2.9 Acrotech Biopharma.
2.9.1 Acrotech Biopharma. Details
2.9.2 Acrotech Biopharma. Major Business
2.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
2.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Acrotech Biopharma. Recent Developments/Updates
2.10 Progenics Pharmaceuticals
2.10.1 Progenics Pharmaceuticals Details
2.10.2 Progenics Pharmaceuticals Major Business
2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
2.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Progenics Pharmaceuticals Recent Developments/Updates
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business
2.11.3 International Isotopes Therapeutic Nuclear Medicines Product and Services
2.11.4 International Isotopes Therapeutic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 International Isotopes Recent Developments/Updates
3 Competitive Environment: Therapeutic Nuclear Medicines by Manufacturer
3.1 Global Therapeutic Nuclear Medicines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2018-2023)
3.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Therapeutic Nuclear Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share in 2022
3.4.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share in 2022
3.5 Therapeutic Nuclear Medicines Market: Overall Company Footprint Analysis
3.5.1 Therapeutic Nuclear Medicines Market: Region Footprint
3.5.2 Therapeutic Nuclear Medicines Market: Company Product Type Footprint
3.5.3 Therapeutic Nuclear Medicines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Therapeutic Nuclear Medicines Market Size by Region
4.1.1 Global Therapeutic Nuclear Medicines Sales Quantity by Region (2018-2029)
4.1.2 Global Therapeutic Nuclear Medicines Consumption Value by Region (2018-2029)
4.1.3 Global Therapeutic Nuclear Medicines Average Price by Region (2018-2029)
4.2 North America Therapeutic Nuclear Medicines Consumption Value (2018-2029)
4.3 Europe Therapeutic Nuclear Medicines Consumption Value (2018-2029)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Consumption Value (2018-2029)
4.5 South America Therapeutic Nuclear Medicines Consumption Value (2018-2029)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2029)
5.2 Global Therapeutic Nuclear Medicines Consumption Value by Type (2018-2029)
5.3 Global Therapeutic Nuclear Medicines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2029)
6.2 Global Therapeutic Nuclear Medicines Consumption Value by Application (2018-2029)
6.3 Global Therapeutic Nuclear Medicines Average Price by Application (2018-2029)
7 North America
7.1 North America Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2029)
7.2 North America Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2029)
7.3 North America Therapeutic Nuclear Medicines Market Size by Country
7.3.1 North America Therapeutic Nuclear Medicines Sales Quantity by Country (2018-2029)
7.3.2 North America Therapeutic Nuclear Medicines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2029)
8.2 Europe Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2029)
8.3 Europe Therapeutic Nuclear Medicines Market Size by Country
8.3.1 Europe Therapeutic Nuclear Medicines Sales Quantity by Country (2018-2029)
8.3.2 Europe Therapeutic Nuclear Medicines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Therapeutic Nuclear Medicines Market Size by Region
9.3.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Therapeutic Nuclear Medicines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2029)
10.2 South America Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2029)
10.3 South America Therapeutic Nuclear Medicines Market Size by Country
10.3.1 South America Therapeutic Nuclear Medicines Sales Quantity by Country (2018-2029)
10.3.2 South America Therapeutic Nuclear Medicines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Country
11.3.1 Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Therapeutic Nuclear Medicines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Therapeutic Nuclear Medicines Market Drivers
12.2 Therapeutic Nuclear Medicines Market Restraints
12.3 Therapeutic Nuclear Medicines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Therapeutic Nuclear Medicines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Therapeutic Nuclear Medicines
13.3 Therapeutic Nuclear Medicines Production Process
13.4 Therapeutic Nuclear Medicines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Therapeutic Nuclear Medicines Typical Distributors
14.3 Therapeutic Nuclear Medicines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Therapeutic Nuclear Medicines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Therapeutic Nuclear Medicines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Therapeutic Nuclear Medicines Product and Services
Table 6. Novartis AG Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis AG Recent Developments/Updates
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Major Business
Table 10. Bayer Therapeutic Nuclear Medicines Product and Services
Table 11. Bayer Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bayer Recent Developments/Updates
Table 13. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 14. China Isotope & Radiation Major Business
Table 15. China Isotope & Radiation Therapeutic Nuclear Medicines Product and Services
Table 16. China Isotope & Radiation Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. China Isotope & Radiation Recent Developments/Updates
Table 18. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 19. Q BioMed Major Business
Table 20. Q BioMed Therapeutic Nuclear Medicines Product and Services
Table 21. Q BioMed Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Q BioMed Recent Developments/Updates
Table 23. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Curium Pharmaceuticals Major Business
Table 25. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 26. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Curium Pharmaceuticals Recent Developments/Updates
Table 28. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 29. Jubilant DraxImage Major Business
Table 30. Jubilant DraxImage Therapeutic Nuclear Medicines Product and Services
Table 31. Jubilant DraxImage Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Jubilant DraxImage Recent Developments/Updates
Table 33. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 34. Dongcheng Major Business
Table 35. Dongcheng Therapeutic Nuclear Medicines Product and Services
Table 36. Dongcheng Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Dongcheng Recent Developments/Updates
Table 38. Lantheus Basic Information, Manufacturing Base and Competitors
Table 39. Lantheus Major Business
Table 40. Lantheus Therapeutic Nuclear Medicines Product and Services
Table 41. Lantheus Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Lantheus Recent Developments/Updates
Table 43. Acrotech Biopharma. Basic Information, Manufacturing Base and Competitors
Table 44. Acrotech Biopharma. Major Business
Table 45. Acrotech Biopharma. Therapeutic Nuclear Medicines Product and Services
Table 46. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Acrotech Biopharma. Recent Developments/Updates
Table 48. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Progenics Pharmaceuticals Major Business
Table 50. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product and Services
Table 51. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Progenics Pharmaceuticals Recent Developments/Updates
Table 53. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 54. International Isotopes Major Business
Table 55. International Isotopes Therapeutic Nuclear Medicines Product and Services
Table 56. International Isotopes Therapeutic Nuclear Medicines Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. International Isotopes Recent Developments/Updates
Table 58. Global Therapeutic Nuclear Medicines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Therapeutic Nuclear Medicines Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 61. Market Position of Manufacturers in Therapeutic Nuclear Medicines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Therapeutic Nuclear Medicines Production Site of Key Manufacturer
Table 63. Therapeutic Nuclear Medicines Market: Company Product Type Footprint
Table 64. Therapeutic Nuclear Medicines Market: Company Product Application Footprint
Table 65. Therapeutic Nuclear Medicines New Market Entrants and Barriers to Market Entry
Table 66. Therapeutic Nuclear Medicines Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Therapeutic Nuclear Medicines Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Therapeutic Nuclear Medicines Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Therapeutic Nuclear Medicines Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Therapeutic Nuclear Medicines Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Therapeutic Nuclear Medicines Average Price by Region (2018-2023) & (USD/Unit)
Table 72. Global Therapeutic Nuclear Medicines Average Price by Region (2024-2029) & (USD/Unit)
Table 73. Global Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Therapeutic Nuclear Medicines Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Therapeutic Nuclear Medicines Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Therapeutic Nuclear Medicines Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Therapeutic Nuclear Medicines Average Price by Type (2018-2023) & (USD/Unit)
Table 78. Global Therapeutic Nuclear Medicines Average Price by Type (2024-2029) & (USD/Unit)
Table 79. Global Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Therapeutic Nuclear Medicines Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Therapeutic Nuclear Medicines Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Therapeutic Nuclear Medicines Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Therapeutic Nuclear Medicines Average Price by Application (2018-2023) & (USD/Unit)
Table 84. Global Therapeutic Nuclear Medicines Average Price by Application (2024-2029) & (USD/Unit)
Table 85. North America Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Therapeutic Nuclear Medicines Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Therapeutic Nuclear Medicines Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Therapeutic Nuclear Medicines Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Therapeutic Nuclear Medicines Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Therapeutic Nuclear Medicines Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Therapeutic Nuclear Medicines Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Therapeutic Nuclear Medicines Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Therapeutic Nuclear Medicines Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Therapeutic Nuclear Medicines Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Therapeutic Nuclear Medicines Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Therapeutic Nuclear Medicines Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Therapeutic Nuclear Medicines Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Therapeutic Nuclear Medicines Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Therapeutic Nuclear Medicines Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Therapeutic Nuclear Medicines Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Therapeutic Nuclear Medicines Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Therapeutic Nuclear Medicines Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Therapeutic Nuclear Medicines Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Therapeutic Nuclear Medicines Raw Material
Table 126. Key Manufacturers of Therapeutic Nuclear Medicines Raw Materials
Table 127. Therapeutic Nuclear Medicines Typical Distributors
Table 128. Therapeutic Nuclear Medicines Typical Customers
List of Figures
Figure 1. Therapeutic Nuclear Medicines Picture
Figure 2. Global Therapeutic Nuclear Medicines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Type in 2022
Figure 4. Radium-223 Examples
Figure 5. Lutetium-177 Examples
Figure 6. Iodine-131 Examples
Figure 7. Other Examples
Figure 8. Global Therapeutic Nuclear Medicines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Application in 2022
Figure 10. Thyroid Examples
Figure 11. Bone Metastasis Examples
Figure 12. Lymphoma Examples
Figure 13. Other Examples
Figure 14. Global Therapeutic Nuclear Medicines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Therapeutic Nuclear Medicines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Therapeutic Nuclear Medicines Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Therapeutic Nuclear Medicines Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Therapeutic Nuclear Medicines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Therapeutic Nuclear Medicines Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Therapeutic Nuclear Medicines Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Therapeutic Nuclear Medicines Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Therapeutic Nuclear Medicines Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Therapeutic Nuclear Medicines Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Therapeutic Nuclear Medicines Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Therapeutic Nuclear Medicines Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Therapeutic Nuclear Medicines Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Therapeutic Nuclear Medicines Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Therapeutic Nuclear Medicines Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Therapeutic Nuclear Medicines Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Therapeutic Nuclear Medicines Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Therapeutic Nuclear Medicines Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Therapeutic Nuclear Medicines Consumption Value Market Share by Region (2018-2029)
Figure 56. China Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Therapeutic Nuclear Medicines Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Therapeutic Nuclear Medicines Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Therapeutic Nuclear Medicines Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Therapeutic Nuclear Medicines Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Therapeutic Nuclear Medicines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Therapeutic Nuclear Medicines Market Drivers
Figure 77. Therapeutic Nuclear Medicines Market Restraints
Figure 78. Therapeutic Nuclear Medicines Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Therapeutic Nuclear Medicines in 2022
Figure 81. Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure 82. Therapeutic Nuclear Medicines Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
